SERF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.711200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.978400E-01
Normal-vs-Stage2
4.443000E-01
Normal-vs-Stage3
5.715000E-01
Normal-vs-Stage4
7.055600E-01
Stage1-vs-Stage2
8.724200E-01
Stage1-vs-Stage3
9.303800E-01
Stage1-vs-Stage4
4.301800E-01
Stage2-vs-Stage3
7.902400E-01
Stage2-vs-Stage4
5.093200E-01
Stage3-vs-Stage4
6.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.915800E-01
Normal-vs-AfricanAmerican
5.273800E-01
Normal-vs-Asian
2.931600E-01
Caucasian-vs-AfricanAmerican
9.211000E-01
Caucasian-vs-Asian
1.924360E-01
AfricanAmerican-vs-Asian
4.352600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.135800E-01
Normal-vs-Female
4.324800E-01
Male-vs-Female
6.914000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.519600E-01
Normal-vs-Age(41-60Yrs)
4.311600E-01
Normal-vs-Age(61-80Yrs)
5.153800E-01
Normal-vs-Age(81-100Yrs)
3.494200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.955400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.045200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.288600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.755800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.765000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.210600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.081800E-01
Normal-vs-Daily Drinker
3.513200E-01
Normal-vs-Weekly Drinker
2.319600E-01
Normal-vs-Occasional Drinker
5.103000E-01
Normal-vs-Social Drinker
6.199200E-01
Non Drinker-vs-Daily Drinker
2.989200E-01
Non Drinker-vs-Weekly Drinker
3.744200E-01
Non Drinker-vs-Occasional Drinker
9.311200E-01
Non Drinker-vs-Social Drinker
7.009000E-01
Daily Drinker-vs-Weekly Drinker
9.152800E-01
Daily Drinker-vs-Occasional Drinker
2.717000E-01
Daily Drinker-vs-Social Drinker
1.508390E-01
Weekly Drinker-vs-Occasional Drinker
2.651800E-01
Weekly Drinker-vs-Social Drinker
1.553190E-01
Occasional Drinker-vs-Social Drinker
7.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.741600E-01
Normal-vs-Grade 2
1.646220E-01
Normal-vs-Grade 3
3.124600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.667420E-01
Grade 1-vs-Grade 3
8.668000E-01
Grade 1-vs-Grade 4
4.741600E-01
Grade 2-vs-Grade 3
3.728000E-02
Grade 2-vs-Grade 4
1.646220E-01
Grade 3-vs-Grade 4
3.124600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.324800E-01
Normal-vs-NonDiabetic
3.322600E-01
Diabetic-vs-NonDiabetic
2.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.963600E-01
Normal-vs-NoPancreatitis
4.475600E-01
Pancreatitis-vs-NoPancreatitis
3.116200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.738400E-01
Normal-vs-N1
4.333400E-01
N0-vs-N1
8.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.066200E-01
Normal-vs-TP53-NonMutant
7.647400E-01
TP53-Mutant-vs-TP53-NonMutant
1.037180E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
